PUMA BIOTECHNOLOGY, INC. Increase (Decrease) in Prepaid Expenses, Other
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Increase (Decrease) in Prepaid Expenses, Other of -$101.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2026-08-06
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2026-06-30 was $15.00K.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2026-03-31 was -$116.00K, a 114.70% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2025-12-31 was $718.00K, a 48.05% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2025-09-30 was $84.00K.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in prepaid expenses, other for fiscal 2025 was $325.00K.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in prepaid expenses, other for fiscal 2024 was -$1.00M.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in prepaid expenses, other for fiscal 2023 was -$820.00K.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in prepaid expenses, other for fiscal 2022 was -$2.37M.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 12 month | Increase (Decrease) in Prepaid Expenses, Other 12 month as first filed | Increase (Decrease) in Prepaid Expenses, Other 45 month | Increase (Decrease) in Prepaid Expenses, Other 48 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$101.00K 10-Q · filed 2026-08-06 | $617.00K derived: sum of 3 quarters · filed 2026-08-06 | $701.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | -$116.00K 10-Q · filed 2026-05-07 | $602.00K derived: sum of 2 quarters · filed 2026-05-07 | $686.00K derived: sum of 3 quarters · filed 2026-05-07 | -$580.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $718.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $802.00K derived: sum of 2 quarters · filed 2026-02-26 | -$464.00K derived: sum of 3 quarters · filed 2026-08-06 | $325.00K 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $84.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.18M derived: sum of 2 quarters · filed 2026-08-06 | -$393.00K 10-Q · filed 2025-11-06 | $989.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | -$1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$477.00K 10-Q · filed 2026-08-06 | $905.00K derived: sum of 3 quarters · filed 2026-08-06 | -$98.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $789.00K 10-Q · filed 2026-05-07 | $2.17M derived: sum of 2 quarters · filed 2026-05-07 | $1.17M derived: sum of 3 quarters · filed 2026-05-07 | $200.00K derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $379.00K derived: sum of 2 quarters · filed 2026-02-26 | -$589.00K derived: sum of 3 quarters · filed 2026-02-26 | -$1.00M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.97M derived: sum of 2 quarters · filed 2025-11-06 | -$2.38M 10-Q · filed 2025-11-06 | -$1.82M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | -$968.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.38M 10-Q · filed 2025-08-07 | -$820.00K derived: sum of 3 quarters · filed 2026-02-26 | -$1.57M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | -$411.00K 10-Q · filed 2025-05-08 | $148.00K derived: sum of 2 quarters · filed 2026-02-26 | -$599.00K derived: sum of 3 quarters · filed 2026-02-26 | -$361.00K derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $559.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$188.00K derived: sum of 2 quarters · filed 2026-02-26 | $50.00K derived: sum of 3 quarters · filed 2026-02-26 | -$820.00K 10-K · filed 2026-02-26 | |||
| 2023-09-30 | -$747.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$509.00K derived: sum of 2 quarters · filed 2024-11-07 | -$1.38M 10-Q · filed 2024-11-07 | -$586.00K derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-06-30 | $238.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$632.00K 10-Q · filed 2024-08-01 | $161.00K derived: sum of 3 quarters · filed 2025-02-27 | -$1.75M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-03-31 | -$870.00K 10-Q · filed 2024-05-02 | -$77.00K derived: sum of 2 quarters · filed 2025-02-27 | -$1.99M derived: sum of 3 quarters · filed 2025-02-27 | -$2.33M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | $793.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$1.12M derived: sum of 2 quarters · filed 2025-02-27 | -$1.46M derived: sum of 3 quarters · filed 2025-02-27 | -$2.37M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | -$1.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$2.26M derived: sum of 2 quarters · filed 2023-11-02 | -$3.16M 10-Q · filed 2023-11-02 | -$3.25M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | -$348.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$1.25M 10-Q · filed 2023-08-03 | -$1.35M derived: sum of 3 quarters · filed 2024-02-29 | -$3.65M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | -$903.00K 10-Q · filed 2023-05-04 | -$998.00K derived: sum of 2 quarters · filed 2024-02-29 | -$3.30M derived: sum of 3 quarters · filed 2024-02-29 | -$3.48M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | -$95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$2.40M derived: sum of 2 quarters · filed 2024-02-29 | -$2.58M derived: sum of 3 quarters · filed 2024-02-29 | -$2.67M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | -$2.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$2.49M derived: sum of 2 quarters · filed 2022-11-03 | -$2.57M 10-Q · filed 2022-11-03 | -$368.00K derived: sum of 4 quarters · filed 2023-03-02 | |||
| 2021-06-30 | -$183.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$271.00K 10-Q · filed 2022-08-04 | $1.94M derived: sum of 3 quarters · filed 2023-03-02 | -$2.60M derived: sum of 4 quarters · filed 2023-03-02 | |||
| 2021-03-31 | -$88.00K 10-Q · filed 2022-05-05 | $2.12M derived: sum of 2 quarters · filed 2023-03-02 | -$2.41M derived: sum of 3 quarters · filed 2023-03-02 | -$3.44M derived: sum of 4 quarters · filed 2023-03-02 | |||
| 2020-12-31 | $2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$2.33M derived: sum of 2 quarters · filed 2023-03-02 | -$3.35M derived: sum of 3 quarters · filed 2023-03-02 | -$2.21M 10-K · filed 2023-03-02 | -$2.25M 10-K · filed 2021-03-01 | ||
| 2020-09-30 | -$4.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$5.55M derived: sum of 2 quarters · filed 2021-11-04 | -$4.41M 10-Q · filed 2021-11-04 | -$1.92M derived: sum of 4 quarters · filed 2022-03-03 | |||
| 2020-06-30 | -$1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $119.00K 10-Q · filed 2021-08-05 | $2.61M derived: sum of 3 quarters · filed 2022-03-03 | $1.96M derived: sum of 4 quarters · filed 2022-03-03 | |||
| 2020-03-31 | $1.14M 10-Q · filed 2021-05-06 | $3.63M derived: sum of 2 quarters · filed 2022-03-03 | $2.98M derived: sum of 3 quarters · filed 2022-03-03 | $1.96M derived: sum of 4 quarters · filed 2022-03-03 | |||
| 2019-12-31 | $2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $1.84M derived: sum of 2 quarters · filed 2022-03-03 | $816.00K derived: sum of 3 quarters · filed 2022-03-03 | -$414.00K 10-K · filed 2022-03-03 | -$568.00K 10-K · filed 2020-02-28 | ||
| 2019-09-30 | -$647.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$1.68M derived: sum of 2 quarters · filed 2020-11-05 | -$2.90M 10-Q · filed 2020-11-05 | -$1.82M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-06-30 | -$1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$2.26M 10-Q · filed 2020-08-06 | -$1.17M derived: sum of 3 quarters · filed 2021-03-01 | -$713.00K derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-03-31 | -$1.23M 10-Q · filed 2020-05-07 | -$146.00K derived: sum of 2 quarters · filed 2021-03-01 | $315.00K derived: sum of 3 quarters · filed 2021-03-01 | -$1.44M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2018-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.54M derived: sum of 2 quarters · filed 2021-03-01 | -$205.00K derived: sum of 3 quarters · filed 2021-03-01 | $840.00K 10-K · filed 2021-03-01 | |||
| 2018-09-30 | $461.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$1.29M derived: sum of 2 quarters · filed 2019-11-07 | -$244.00K 10-Q · filed 2019-11-07 | $1.61M derived: sum of 4 quarters · filed 2020-02-28 | |||
| 2018-06-30 | -$1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$705.00K 10-Q · filed 2019-08-09 | $1.15M derived: sum of 3 quarters · filed 2020-02-28 | $2.31M derived: sum of 4 quarters · filed 2020-02-28 | |||
| 2018-03-31 | $1.04M 10-Q · filed 2019-05-10 | $2.90M derived: sum of 2 quarters · filed 2020-02-28 | $4.07M derived: sum of 3 quarters · filed 2020-02-28 | $2.70M derived: sum of 4 quarters · filed 2020-02-28 | |||
| 2017-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $3.02M derived: sum of 2 quarters · filed 2020-02-28 | $1.66M derived: sum of 3 quarters · filed 2020-02-28 | $1.14M 10-K · filed 2020-02-28 | |||
| 2017-09-30 | $1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | -$196.00K derived: sum of 2 quarters · filed 2018-11-05 | -$712.00K 10-Q · filed 2018-11-05 | -$1.29M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2017-06-30 | -$1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$1.88M 10-Q · filed 2018-08-09 | -$2.46M derived: sum of 3 quarters · filed 2019-03-01 | -$4.42M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2017-03-31 | -$516.00K 10-Q · filed 2018-05-10 | -$1.10M derived: sum of 2 quarters · filed 2019-03-01 | -$3.06M derived: sum of 3 quarters · filed 2019-03-01 | -$4.10M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2016-12-31 | -$581.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$2.54M derived: sum of 2 quarters · filed 2019-03-01 | -$3.58M derived: sum of 3 quarters · filed 2019-03-01 | -$3.41M 10-K · filed 2019-03-01 | |||
| 2016-09-30 | -$1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$3.00M derived: sum of 2 quarters · filed 2017-11-09 | -$2.83M 10-Q · filed 2017-11-09 | -$2.58M derived: sum of 4 quarters · filed 2018-03-09 | |||
| 2016-06-30 | -$1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$871.00K 10-Q · filed 2017-08-09 | -$619.00K derived: sum of 3 quarters · filed 2018-03-09 | $187.00K derived: sum of 4 quarters · filed 2018-03-09 | |||
| 2016-03-31 | $170.00K 10-Q · filed 2017-05-10 | $422.00K derived: sum of 2 quarters · filed 2018-03-09 | $1.23M derived: sum of 3 quarters · filed 2018-03-09 | $1.26M derived: sum of 4 quarters · filed 2018-03-09 | |||
| 2015-12-31 | $252.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $1.06M derived: sum of 2 quarters · filed 2018-03-09 | $1.09M derived: sum of 3 quarters · filed 2018-03-09 | $958.00K 10-K · filed 2018-03-09 | |||
| 2015-09-30 | $806.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $837.00K derived: sum of 2 quarters · filed 2016-11-09 | $706.00K 10-Q · filed 2016-11-09 | $3.70M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$100.00K 10-Q · filed 2016-08-09 | $2.89M derived: sum of 3 quarters · filed 2017-03-01 | $3.39M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | -$131.00K 10-Q · filed 2016-05-10 | $2.86M derived: sum of 2 quarters · filed 2017-03-01 | $3.36M derived: sum of 3 quarters · filed 2017-03-01 | $8.31M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | $2.99M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $3.49M derived: sum of 2 quarters · filed 2017-03-01 | $8.44M derived: sum of 3 quarters · filed 2017-03-01 | $8.58M 10-K · filed 2017-03-01 | |||
| 2014-09-30 | $497.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $5.45M derived: sum of 2 quarters · filed 2015-11-09 | $5.59M 10-Q · filed 2015-11-09 | $7.96M derived: sum of 4 quarters · filed 2016-02-29 | $13.31M 10-Q · filed 2014-11-10 | ||
| 2014-06-30 | $4.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $5.10M 10-Q · filed 2015-08-10 | $7.47M derived: sum of 3 quarters · filed 2016-02-29 | $9.98M derived: sum of 4 quarters · filed 2016-02-29 | $12.81M 10-Q · filed 2014-08-11 | ||
| 2014-03-31 | $145.00K 10-Q · filed 2015-05-11 | $2.52M derived: sum of 2 quarters · filed 2016-02-29 | $5.03M derived: sum of 3 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $4.88M derived: sum of 2 quarters · filed 2016-02-29 | $6.73M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $2.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $4.36M 10-Q · filed 2014-11-10 | |||||
| 2013-06-30 | $1.84M 10-Q · filed 2014-08-11 | ||||||
| 2012-12-31 | $707.00K 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |